CAPTRUST Financial Advisors
ORGO icon

CAPTRUST Financial Advisors’s Organogenesis Holdings ORGO Stock Holding History

CAPTRUST Financial Advisors’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$48.8K Buy
+20,074
New +$49.1K ﹤0.01% 3139
2025
Q2 		– Sell
-10,574
Closed -$45.7K – 2577
2025
Q1 		$45.7K Sell
10,574
-1,096
-9% -$4.42K ﹤0.01% 2288
2024
Q4 		$37.3K Sell
11,670
-939
-7% -$3.15K ﹤0.01% 2253
2024
Q3 		$36.1K Buy
+12,609
New +$35.4K ﹤0.01% 2247
2022
Q2 		– Sell
-2,220
Closed -$17K – 5078
2022
Q1 		$17K Buy
+2,220
New +$17.2K ﹤0.01% 3495

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

CAPTRUST Financial Advisors's ORGO Position: Q2 2026 in Review

CAPTRUST Financial Advisors opened a new position in Organogenesis Holdings (ORGO) in Q2 2026: 20,074 shares worth $48.8K. The stake represents ﹤0.01% of the portfolio and ranks #3139 among its holdings. This is a return to the name: CAPTRUST Financial Advisors previously reported a position in ORGO as recently as Q1 2025.

CAPTRUST Financial Advisors first reported a position in ORGO in Q1 2022 and has held it in 5 quarters since. 136 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

  • CAPTRUST Financial Advisors held 20,074 shares of Organogenesis Holdings worth $48.8K as of Q2 2026.
  • Organogenesis Holdings was a new CAPTRUST Financial Advisors position in Q2 2026.
  • Organogenesis Holdings made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q2 2026, its #3139 holding.
  • CAPTRUST Financial Advisors first reported a position in Organogenesis Holdings in Q1 2022 and has held it in 5 quarters since.
  • 136 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.